GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia

NCT02799147 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Leukemia, Acute Lymphoblastic
Acute Myeloid Leukemia
Mixed-Lineage Acute Leukemias

Interventions

PROCEDURE: Allogeneic stem cell transplantation
DRUG: Fludarabine monophosphate
DRUG: Busulfan
DRUG: Bendamustine

Sponsor

St. Petersburg State Pavlov Medical University